| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| (R)-Metomidate |
依托咪酯雜質(zhì) |
61045-91-8 |
詳細
|
| Etomidate EP Impurity A |
依托咪酯雜質(zhì)A |
3157-27-5 |
詳細
|
| GDC-6036 |
GDC6036 |
2417987-45-0 |
詳細
|
| CNX-1351 |
CNX1351 |
1276105-89-5 |
詳細
|
| BOS318 |
化合物BOS-318 |
2387633-15-8 |
詳細
|
| (S)-Remoxipride Hydrochloride |
瑞莫必利鹽酸鹽 |
73220-03-8 |
詳細
|
| INS3-54A18 |
3-(4-氯亞芐基)-1-(4-羥苯基)-5-苯基-1H-吡咯-2(3H)-酮 |
328998-53-4 |
詳細
|
| BM635 |
BM635 |
1493762-74-5 |
詳細
|
| Atopaxar Hydrobromide |
2-(5,6-二乙氧基-7-氟-1,3-二氫-1-亞氨基-2H-異吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-嗎啉基)苯基]乙酮 |
751475-53-3 |
詳細
|
| NE-100 hydrochloride |
N,N-二乙基-2-(4-甲氧基-3-苯乙基氧基苯基)乙胺鹽酸鹽 |
149409-57-4 |
詳細
|
| Nomifensine maleate |
諾米芬新馬來酸鹽 |
32795-47-4 |
詳細
|
| Auten-99 HBr |
2-([1,1'-聯(lián)苯]-4-基)-5,6-二氫咪唑并[2,1-b]噻唑氫溴酸鹽 |
1049780-58-6 |
詳細
|
| RBM013209 |
RBN013209 |
2597933-17-8 |
詳細
|
| SCH529074 |
SCH 529074 |
922150-11-6 |
詳細
|
| SAR407899 |
6-(4-哌啶基氧基)-1(2H)-異喹啉酮 |
923359-38-0 |
詳細
|
| CGP-53716 |
N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)苯甲酰胺 |
152459-94-4 |
詳細
|
| ST034307 |
6-氯-2-(三氯甲基)-4H-苯并吡喃-4-酮 |
133406-29-8 |
詳細
|
| R-10015 |
2-(1-(5-氯-7H-吡咯并[2,3-D]嘧啶-4-基)哌啶-4-基)-1H-苯并[D]咪唑-6-羧酸甲酯 |
2097938-51-5 |
詳細
|
| UPF1069 |
5-(2-氧代-2-苯基乙氧基)-1(2H)-異喹啉酮 |
1048371-03-4 |
詳細
|
| CB-7921220 |
6-(4-氨基苯乙烯基)吡啶-2-羧酸 |
115453-99-1 |
詳細
|
| EB-3D |
1,1'-(((乙烷-1,2-二基雙(氧基))雙(4,1-亞苯基))雙(亞甲基))雙(4-(二甲氨基)吡啶-1-鎓)溴化物 |
1839150-63-8 |
詳細
|
| ML402 |
298684-44-3 |
298684-44-3 |
詳細
|
| BM212 |
1-((1,5-二(4-氯苯基)-2-甲基-1H-吡咯-3-基)甲基)-4-甲基哌嗪 |
146204-42-4 |
詳細
|
| Eprotirome |
3-((3,5-二溴-4-(4-羥基-3-異丙基苯氧基)苯基)氨基)-3-氧代丙酸 |
355129-15-6 |
詳細
|
| KY1220 |
5-((1-(4-硝基苯基)-1H-吡咯-2-基)亞甲基)-2-硫代咪唑烷-4-酮 |
292168-79-7 |
詳細
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
詳細
|
| Y06036 |
5-溴-2-甲氧基-N-(6-甲氧基-3-甲基苯并[d]異惡唑-5-基)苯磺酰胺 |
1832671-96-1 |
詳細
|
| Loreclezole |
(Z)-1-(2-氯-2-(2,4-二氯苯基)乙烯基)-1H-1,2,4-三唑 |
117857-45-1 |
詳細
|
| FK-3311 |
N-[4-乙酰基-2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺 |
116686-15-8 |
詳細
|
| A 438079 hydrochloride |
3-[[5-(2,3-二氯苯基)-1H-四唑-1-基]甲基]吡啶單鹽酸鹽 |
899431-18-6 |
詳細
|
| N-[2-methoxy-5-(trifluoromethyl)phenyl]acetamide |
N-(2-甲氧基-5-(三氟甲基)苯基)乙酰胺 |
40622-64-8 |
詳細
|
| MJN110 |
2,5-二氧吡咯烷-1-基4-(雙(4-氯苯基)甲基)哌嗪-1-羧酸酯 |
1438416-21-7 |
詳細
|
| C-DIM 12 |
C-DIM12 |
178946-89-9 |
詳細
|
| ASP7663 |
ASP 7663;ASP-7663;ASP7663 |
1190217-35-6 |
詳細
|
| Selexipag Impurity |
Acetamide, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]- |
475086-28-3 |
詳細
|
| 1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
1-(2-(3-甲?；?N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-聯(lián)苯]-2-基氨基甲酸酯 |
864760-28-1 |
詳細
|
| UniPR1331 |
UniPR1331 |
1809170-59-9 |
詳細
|
| PIP-199 |
PIP-199 |
622795-76-0 |
詳細
|
| NS 398 |
N-[2-(環(huán)己氧基)-4-硝基苯基]甲基磺酰胺 |
123653-11-2 |
詳細
|
| 9H-Purin-2-amine, 6-chloro-9-[(2R)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]- |
|
881881-89-6 |
詳細
|
| Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) |
萊特莫韋雜質(zhì) |
917389-30-1 |
詳細
|
| NITD-349 |
N-(4,4-二甲基環(huán)己基)-4,6-二氟-1H-吲哚-2-甲酰胺 |
1473450-62-2 |
詳細
|
| Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride |
1,3,5-三甲基金剛烷胺鹽酸鹽 |
15210-60-3 |
詳細
|
| Urea, N-(2-broMo-6-fluorophenyl)-N'-[2-Methoxy-5-(trifluoroMethyl)phenyl]- |
萊特莫韋雜質(zhì) |
917389-23-2 |
詳細
|
| VK-II-36 |
化合物VK-II-43 |
955371-66-1 |
詳細
|
| ML67-33 |
ML67-33 |
1443290-89-8 |
詳細
|
| AF40431 |
AF40431 |
181125-92-8 |
詳細
|
| N-Acetyl DeMethyl MeMantine |
N-乙酰基去甲基美金剛 |
778-09-6 |
詳細
|
| 7-Acetamido-1,3,5-trimethyladamantane |
3,5,7-三甲基-1-金剛烷乙酰胺 |
15210-64-7 |
詳細
|
| MSDC-0602 |
5-(4-(2-(3-甲氧基苯基)-2-氧代乙氧基)芐基)噻唑烷-2,4-二酮 |
1133819-87-0 |
詳細
|
| INDEX NAME NOT YET ASSIGNED |
|
2761681-01-8 |
詳細
|
| 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)- |
來特莫韋雜質(zhì) |
2991059-71-1 |
詳細
|
| ethyl (2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate |
|
2864383-32-2 |
詳細
|
| Picotamide |
吡考胺 |
32828-81-2 |
詳細
|
| Cariprazine Impurity |
卡利拉嗪雜質(zhì)6 |
1231947-89-9 |
詳細
|
| 2-Propenamide, N-(2-bromo-6-fluorophenyl)- |
來特莫韋雜質(zhì) |
1695869-28-3 |
詳細
|
| 2-Propenoic acid, 3-(2-amino-3-fluorophenyl)-, methyl ester, (2E)- |
來特莫韋雜質(zhì) |
690664-20-1 |
詳細
|
| AU1235 |
1338780-86-1 |
1338780-86-1 |
詳細
|
| C-215 |
N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine |
912780-51-9 |
詳細
|
| 2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]- |
吉列替尼N-1 |
2043019-99-2 |
詳細
|
| Benzoic acid, 2-hydroxy-, compd. with (2E)-methyl 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-2-propenoate (1:1) |
/ |
1791412-05-9 |
詳細
|
| GSK3359088 |
GSK 3359088 |
1628830-21-6 |
詳細
|
| NLRP3/AIM2-IN-2 |
化合物 NLRP3/AIM2-IN-2 |
791840-86-3 |
詳細
|
| CMP-5 HCl |
化合物CMP-5鹽酸鹽 |
2309409-79-6 |
詳細
|
| Resorcinolnaphthalein |
Resorcinolnaphthalein |
41307-63-5 |
詳細
|
| WAY-313356 |
1-苯基-2-((4-苯基-5-(吡啶-4-基)-4H-1,2,4-三唑-3-基)硫基)乙酮 |
325694-03-9 |
詳細
|
| SULFATE-IONOPHORE I |
1,1'-(1,3-亞苯基雙(亞甲基))雙(3-苯 |
37042-63-0 |
詳細
|
| 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bR,4aS)- |
2-((3bR,4aS)-5,5-二氟-3-(三氟甲基)-3b,4,4a,5-四氫-1H-環(huán)丙烷[3,4]環(huán)戊[1,2-c]吡唑-1 -基)乙酸 |
2189680-65-5 |
詳細
|
| CBD3063 |
|
1281060-70-5 |
詳細
|
| Teriflunomide Impurity |
特立氟胺雜質(zhì) |
69066-42-8 |
詳細
|
| Hepln-13 |
2-(4-溴苯基)-2,3-二氫-1H-呸啶 |
64369-13-7 |
詳細
|
| 1H-Indole, 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-iodo- |
5-溴-3-(3-((叔丁基二苯基甲硅烷基)氧基)-2,2-二甲基丙基)-2-碘-1H-吲哚 |
2641451-43-4 |
詳細
|
| raf kinase-IN-1 |
5-氯-3-(3,5-二溴-4-羥基亞芐基)吲哚啉-2-酮 |
220904-99-4 |
詳細
|
| Eltanexor(KPT-8602) |
CS-2388 |
1642300-52-4 |
詳細
|
| 3-Oxetanemethanamine, 3-phenyl- |
3-苯基-3-胺甲基-1-氧雜環(huán)丁烷 |
497239-45-9 |
詳細
|
| M-31850 |
化合物M-31850 |
281224-40-6 |
詳細
|
| 2-(5-(aminomethyl)-1,2,4-oxadiazol-3-yl)-N-((3S,4R)-1,3-dimethylpiperidin-4-yl)-1-(2,2,2-trifluoroethyl)-1H-indol-4-amine hydrochloride |
RMC9805中間體 |
2865128-45-4 |
詳細
|
| Upadacitinib Impurity |
烏帕替尼雜質(zhì) |
1201187-46-3 |
詳細
|
| FQ |
4(1H)-Quinazolinone, 2-(4-fluorophenyl)- |
190838-76-7 |
詳細
|
| Alrestatin |
阿瑞司他丁 |
51411-04-2 |
詳細
|
| MV1035 |
NAV1.2/1.6通道阻滯劑1 |
1199944-04-1 |
詳細
|
| Difluorinated Curcumin |
CDF |
1170354-22-9 |
詳細
|
| 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- |
2-((3bS,4aR)-5,5-二氟-3-(三氟甲基)-3b,4,4a,5-四氫-1H-環(huán)丙烯并[3,4]環(huán)戊二烯并[1,2-c]吡唑-1-基)乙酸 |
1620056-83-8 |
詳細
|
| Alexidine dihydrochloride |
阿來西定 二鹽酸鹽 |
1715-30-6 |
詳細
|
| ST1237 |
|
1380593-17-8 |
詳細
|
| PDD 00017273 |
1945950-21-9 |
1945950-21-9 |
詳細
|
| Tyrosinase-IN-2 |
化合物TYROSINASE-IN-2 |
180864-33-9 |
詳細
|
| Letomovir Impurity 13 |
來特莫韋雜質(zhì)13 |
2991059-69-7 |
詳細
|
| trans-3-(benzyloxy)cyclobutanol |
反式-3-(芐氧基)環(huán)丁烷-1-醇 |
1383813-54-4 |
詳細
|
| TERT-BUTYL 3-(4-(METHOXYCARBONYL)PHENYL)AZETIDINE-1-CARBOXYLATE |
3-(4-(甲氧基羰基)苯基)氮雜環(huán)丁烷-1-羧酸叔丁酯 |
1240970-70-0 |
詳細
|
| GSK-7975A |
1253186-56-9 |
1253186-56-9 |
詳細
|
| SSAA09E1 |
SSAA09E1 |
433212-75-0 |
詳細
|
| Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate |
(S)-3-[(S)-4-Boc-嗎啉-2-基]-2-(Cbz-氨基)丙酸甲酯 |
2641824-60-2 |
詳細
|
| Milnacipran Impurity |
米那普侖雜質(zhì) |
1353644-49-1 |
詳細
|
| ZM 447439 |
ZM 447439 |
331771-20-1 |
詳細
|
| Capadenoson (BAY 68-4986) |
卡帕諾生 |
544417-40-5 |
詳細
|
| NA |
|
2411972-48-8 |
詳細
|
| 2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid, methyl ester, (4S)- |
鹽酸鹽 |
3034241-21-6 |
詳細
|
| BI-78D3 |
4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-2,4-DIHYDRO-5-[(5-NITRO-2-THIAZOLYL)THIO]-3H-1,2,4-TRIAZOL-3-ONE |
883065-90-5 |
詳細
|
| GSK3008348 |
GSK-3008348 |
1629249-33-7 |
詳細
|
| NSC 756093 |
NSC 756093 |
1629908-92-4 |
詳細
|
| 3-fluoroazetidine-1-sulfonyl chloride |
3-氟氮雜環(huán)丁烷-1-磺酰氯 |
1411940-38-9 |
詳細
|